{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:09:51Z","timestamp":1777856991417,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.3233\/jnd-200483","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:09:32Z","timestamp":1589548172000},"page":"217-229","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Phenotypes of DMD Exon 51 Skip Equivalent Deletions: A Systematic Review"],"prefix":"10.1177","volume":"7","author":[{"given":"Megan A.","family":"Waldrop","sequence":"first","affiliation":[{"name":"The Center for Gene Therapy, Nationwide Children\u2019s Hospital, Columbus, OH, USA"},{"name":"Departments of Neurology and Pediatrics, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"FILNEMUS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabah Ben","family":"Yaou","sequence":"additional","affiliation":[{"name":"Center of Research in Myology, Sorbonne Universit\u00e9 - Inserm UMRS 974; Databases unit; APHP, Nord\/Est\/Ile-de-France Neuromuscular reference center, Institut de Myologie, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin K.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Sarepta Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann S.","family":"Martin","sequence":"additional","affiliation":[{"name":"Parent Project Muscular Dystrophy, Hackensack, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"O\u2019Rourke","sequence":"additional","affiliation":[{"name":"Sarepta Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ferlini","sequence":"additional","affiliation":[{"name":"U.O. Genetica Medica, Azienda Ospedaliero-Universitaria di Ferrara"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[{"name":"Dubowitz Neuromuscular Centre, Molecular Neurosciences Section, Developmental Neuroscience Programme, UCL Great Ormond Street Institute of Child Health, London, United Kingdom"},{"name":"NIHR Great Ormond Street Hospital Biomedical Research Centre, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Leturcq","sequence":"additional","affiliation":[{"name":"APHP, Laboratoire de G\u00e9n\u00e9tique et Biologie Mol\u00e9culaires, HUPC H\u00f4pital Cochin, Paris, France; Center of Research in Myology, Sorbonne Universit\u00e9 - Inserm UMRS 974"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Tuffery-Giraud","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Montpellier, Laboratoire de G\u00e9n\u00e9tique de Maladies Rares, Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, The University of Utah, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Flanigan","sequence":"additional","affiliation":[{"name":"The Center for Gene Therapy, Nationwide Children\u2019s Hospital, Columbus, OH, USA"},{"name":"Departments of Neurology and Pediatrics, The Ohio State University, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"3","key":"10.3233\/JND-200483_ref1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann Neurol"},{"issue":"10","key":"10.3233\/JND-200483_ref2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.3233\/JND-200483_ref3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum Mutat"},{"issue":"2","key":"10.3233\/JND-200483_ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule","volume":"34","author":"Aartsma-Rus","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.3233\/JND-200483_ref5","unstructured":"Alan EH Emery e. Diagnostic Criteria for Neuromuscular Disorders, 2nd edition. London: Royal Society of Medicine Pr Ltd; 1997. 104 p."},{"issue":"1","key":"10.3233\/JND-200483_ref6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.3233\/JND-200483_ref7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/humu.21114","article-title":"Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort","volume":"30","author":"Flanigan","year":"2009","journal-title":"Hum Mutat"},{"issue":"5","key":"10.3233\/JND-200483_ref8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JND-200483_ref9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JND-200483_ref10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JND-170272","article-title":"Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History","volume":"5","author":"Kinane","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"24","key":"10.3233\/JND-200483_ref11","doi-asserted-by":"crossref","first-page":"e2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JND-200483_ref12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.24365","article-title":"Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45","volume":"77","author":"Findlay","year":"2015","journal-title":"Ann Neurol"},{"issue":"6","key":"10.3233\/JND-200483_ref13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase","volume":"30","author":"Tuffery-Giraud","year":"2009","journal-title":"Hum Mutat"},{"key":"10.3233\/JND-200483_ref14","doi-asserted-by":"crossref","first-page":"32439","DOI":"10.1038\/srep32439","article-title":"Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies","volume":"6","author":"Bello","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.3233\/JND-200483_ref15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nmd.2010.01.013","article-title":"Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients","volume":"20","author":"Helderman-van den Enden","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.3233\/JND-200483_ref16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/jhg.2016.152","article-title":"Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of exon skipping therapy","volume":"62","author":"Nakamura","year":"2017","journal-title":"J Hum Genet"},{"issue":"6","key":"10.3233\/JND-200483_ref17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCGENETICS.109.867242","article-title":"Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy","volume":"2","author":"Kaspar","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"13","key":"10.3233\/JND-200483_ref18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00029330-200607010-00004","article-title":"A different spectrum of DMD gene mutations in local Chinese patients with Duchenne\/Becker muscular dystrophy","volume":"119","author":"Lo","year":"2006","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.3233\/JND-200483_ref19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.nmd.2009.08.011","article-title":"Point mutations in Czech DMD\/BMD patients and their phenotypic outcome","volume":"19","author":"Sedlackova","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-200483_ref20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2350-14-29","article-title":"MLPA-based genotype-phenotype analysis in Chinese patients with DMD\/BMD","volume":"14","author":"Yang","year":"2013","journal-title":"BMC Med Genet"},{"issue":"4","key":"10.3233\/JND-200483_ref21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1566523218666180709125346","article-title":"Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance","volume":"18","author":"Perez-Sanchez","year":"2018","journal-title":"Curr Gene Ther"},{"issue":"3","key":"10.3233\/JND-200483_ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"issue":"3","key":"10.3233\/JND-200483_ref24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.21426","article-title":"Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene","volume":"32","author":"Flanigan","year":"2011","journal-title":"Hum Mutat"},{"issue":"5","key":"10.3233\/JND-200483_ref25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/hmg\/ddu537","article-title":"Becker muscular dystrophy severity is linked to the structure of dystrophin","volume":"24","author":"Nicolas","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"22","key":"10.3233\/JND-200483_ref26","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1212\/WNL.0000000000001025","article-title":"Dystrophin quantification: Biological and translational research implications","volume":"83","author":"Anthony","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.3233\/JND-200483_ref27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2990.2012.01250.x","article-title":"Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens","volume":"38","author":"Taylor","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"10.3233\/JND-200483_ref28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nmd.2010.04.005","article-title":"Best practice guidelines on molecular diagnostics in Duchenne\/Becker muscular dystrophies","volume":"20","author":"Abbs","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"Suppl 2","key":"10.3233\/JND-200483_ref29","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1542\/peds.2018-0333C","article-title":"Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy","volume":"142","author":"Leigh","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.3233\/JND-200483_ref30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann Neurol"},{"issue":"5","key":"10.3233\/JND-200483_ref31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajhg.2016.08.023","article-title":"Association Study of Exon Variants in the NF-kappaB and TGFbeta Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy","volume":"99","author":"Bello","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.3233\/JND-200483_ref32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.24370","article-title":"Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study","volume":"77","author":"Bello","year":"2015","journal-title":"Ann Neurol"},{"issue":"10","key":"10.3233\/JND-200483_ref33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp-2014-308409","article-title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants","volume":"86","author":"van den Bergen","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.3233\/JND-200483_ref36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)","volume":"155","author":"Ciafaloni","year":"2009","journal-title":"J Pediatr"},{"issue":"11","key":"10.3233\/JND-200483_ref37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0883073810362762","article-title":"Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy","volume":"25","author":"Matthews","year":"2010","journal-title":"J Child Neurol"},{"issue":"1","key":"10.3233\/JND-200483_ref38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0883073813517263","article-title":"Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001","volume":"30","author":"Fox","year":"2015","journal-title":"J Child Neurol"},{"issue":"10","key":"10.3233\/JND-200483_ref39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4187\/respcare.04676","article-title":"Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011","volume":"61","author":"Andrews","year":"2016","journal-title":"Respir Care"},{"issue":"8","key":"10.3233\/JND-200483_ref40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.nmd.2017.05.019","article-title":"Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy","volume":"27","author":"Kim","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-200483_ref41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.3233\/JND-200483_ref42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.3233\/JND-200483_ref44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1073\/pnas.1220256110","article-title":"Molecular dissection of dystrophin identifies the docking site for nNOS","volume":"110","author":"Harper","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.3233\/JND-200483_ref45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/humu.22479","article-title":"The ZZ domain of dystrophin in DMD: making sense of missense mutations","volume":"35","author":"Vulin","year":"2014","journal-title":"Hum Mutat"},{"issue":"6","key":"10.3233\/JND-200483_ref46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ana.410440619","article-title":"A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype","volume":"44","author":"Goldberg","year":"1998","journal-title":"Ann Neurol"},{"issue":"1","key":"10.3233\/JND-200483_ref47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.134.1.93","article-title":"Forced expression of dystrophin deletion constructs reveals structure-function correlations","volume":"134","author":"Rafael","year":"1996","journal-title":"J Cell Biol"},{"issue":"Suppl 1","key":"10.3233\/JND-200483_ref48","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0960-8966(02)00078-0","article-title":"Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin","volume":"12","author":"Scott","year":"2002","journal-title":"Neuromuscul Disord"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-200483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:28Z","timestamp":1777506568000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-200483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":44,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jnd-200483","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}